Cite
HARVARD Citation
Gruson, D. et al. (2015). Comparison of fibroblast growth factor 23, soluble ST2 and Galectin-3 for prognostication of cardiovascular death in heart failure patients. International journal of cardiology. pp. 185-187. [Online].